Citace podle APA (7th ed.)

Palmer, B. F., & Clegg, D. J. (2021). Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy. Clinical journal of the American Society of Nephrology, 16(8), 1284. https://doi.org/10.2215/CJN.17621120

Citace podle Chicago (17th ed.)

Palmer, Biff F., a Deborah J. Clegg. "Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy." Clinical Journal of the American Society of Nephrology 16, no. 8 (2021): 1284. https://doi.org/10.2215/CJN.17621120.

Citace podle MLA (9th ed.)

Palmer, Biff F., a Deborah J. Clegg. "Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy." Clinical Journal of the American Society of Nephrology, vol. 16, no. 8, 2021, p. 1284, https://doi.org/10.2215/CJN.17621120.

Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..